| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |